AIM: The French population is facing the COVID-19 pandemic and the health systems have been reoriented in emergency for the care of patients with coronavirus. The management of cancers of the urinary and male genital tracts must be adapted to this context. MATERIAL AND METHOD: An expert opinion documented by a literature review was formulated by the Cancerology Committee of the French Association of Urology (CCAFU). RESULTS: The medical and surgical management of patients with any cancers of the urinary and male genital tracts must be adapted by modifying the consultation methods, by prioritizing interventions according to the intrinsic prognosis of cancers, taking into account the patient's comorbidities. The protection of urologists from COVID-19 must be considered. CONCLUSION: The CCAFU issues an expert opinion on the measure to be taken to adapt the management of cancers of the male urinary and genital tract to the context of pandemic by COVID-19. [[[fr]]]Resume Objectif: La population francaise est confrontee a la pandemie de COVID-19 et le systemes de sante a ete reoriente en urgence pour la prise en charge des patients atteint du coronavirus. La prise en charge des cancers de l'appareil urinaire et genital masculin doit etre adaptee a ce contexte. Materiel et methode: Un avis d'experts documente par une revue de la litterature a ete formule par le Comite de Cancerologie de l'Association Francaise d'Urologie (CCAFU). Resultats: La prise en charge medicale et chirurgicale des patients atteint de cancers de l'appareil urinaire et genital masculin doit etre adaptee en modifiant les modalites de consultation, en priorisant les interventions en fonction du pronostic intrinseque des cancers en tenant compte des comorbidites du patient. La protection des urologues vis-a-vis du COVID-19 doit etre prise en consideration. CONCLUSION: Le CCAFU emet un avis d'experts quant aux mesures a prendre pour adapter la prise en charge des cancers de l'appareil urinaire et genital masculin au contexte de pandemie par COVID-19.